https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 A decision aid for women considering neoadjuvant systemic therapy for operable invasive breast cancer: development and protocol of a phase II evaluation study (ANZ1301 DOMINO) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23048 Wed 11 Apr 2018 11:36:49 AEST ]]> A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30174 Thu 28 Oct 2021 13:02:52 AEDT ]]> Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36683 Thu 17 Feb 2022 09:29:01 AEDT ]]> Neoadjuvant chemotherapy: what does it take to tAnGo? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19710 Sat 24 Mar 2018 07:53:42 AEDT ]]> Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53063 Fri 17 Nov 2023 11:35:16 AEDT ]]>